Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines
European Pharmaceutical Review
JUNE 29, 2022
Novavax is particularly sensitive to this matter and is looking for alternatives that will not only benefit the patients but align with a more ethical solution. First, we see a global trend of developing more ethical solutions for the safety testing of biologics. How are regulatory guidelines adapting to this trend? PathoQuest.
Let's personalize your content